Human Microbiome Market Trends, Analysis, Top Players 2031
The human microbiome market size is projected to reach US$ 4.84 billion by 2031 from US$ 1.07 billion in 2023; the market is estimated to register a CAGR of 20.8% during 2023–2031. The emergence of precision medicine is likely to act as a key trend in the market in the coming years.
Human Microbiome Market Analysis
The human microbiome industry's growth, innovation, and market dynamics are greatly influenced by the investments made by major players in the market. Major players are engaged in making significant investments in research and development to create novel probiotics, diagnostics, and treatments based on the microbiome. These expenditures stimulate innovation, identifying new strains, modes of action, and medicinal uses. Clinical trials receive a large amount of funding, which is essential for demonstrating the effectiveness and safety of products based on the microbiome. For example, Kanvas Biosciences, a pioneer in microbiome mapping technology, announced a US$ 12 million Pre-Series A funding round in June 2023. The company's proprietary platform technology, which has the potential to transform drug development for illnesses linked to the microbiome, will be further developed with the help of the investment. These partnerships make sharing resources, know-how, and technological advancements easier, speeding up product development.
Additionally, notable investors such as Seventure Partners and Flagship Pioneering are actively funding companies that analyze microbiome data, reflecting a growing recognition of the microbiome's role in health. Thus, significant investment in research and development likely drives advancements in precision medicine and therapeutic interventions, thereby creating ample opportunities in the market.
Human Microbiome Market Overview
New pharmaceuticals in the pipeline, product development and enhancement, and an increase in strategic partnerships are significant factors benefiting the microbiome therapies market in China. Xbiome Inc., a leading AI-driven microbiome therapeutics firm, acquired the clinical-stage M201 program from Assembly Biosciences, Inc., a clinical-stage biotechnology company involved in developing cutting-edge treatments for viral disorders such as hepatitis B. The increasing prevalence of target disorders is expected to drive the growth of the human microbiome market. In China, in the future, as research continues to reveal the significant role of the human microbiome in various health conditions, there is a growing interest in developing microbiome-based therapies. This is particularly true for conditions such as gastrointestinal disorders, autoimmune diseases, and metabolic disorders, where the microbiome's influence is well-established. The potential of microbiome therapeutics as more effective and personalized treatments presents a promising opportunity for market expansion. People in China have an IBS prevalence of 2.3–15.8%, according to National Institute of Health statistics released in June 2021.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Human Microbiome Market: Strategic Insights
Market Size Value in US$ 718.95 Million in 2021 Market Size Value by US$ 2,921.68 Million by 2028 Growth rate CAGR of 22.2% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Human Microbiome Market: Strategic Insights
| Market Size Value in | US$ 718.95 Million in 2021 |
| Market Size Value by | US$ 2,921.68 Million by 2028 |
| Growth rate | CAGR of 22.2% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Human Microbiome Market Drivers and Opportunities
Government Initiatives
Government initiatives and support programs significantly impact the human microbiome market growth. Governments frequently give large sums of money and grants for studies on the human microbiome. This financial assistance speeds up the development of novel treatments, devices, and diagnostics. Funding supports the innovation and commercialization of products by startups and small-to-medium-sized enterprises (SMEs) in the human microbiome sector. For instance, NIH launches a human microbiome project. This project can transform how we understand human health and prevent, diagnose, and treat various conditions. Part of the NIH's Roadmap for Medical Research, the Human Microbiome Project will award US$ 115 million to researchers over the next five years. Microbiome-based therapeutics is a booming field. The interest in microbiome-based therapies has increased due to the recent approval of Vowst, a medication from Seres Therapeutics, to treat C. difficile infections. Reclassifying microbiome probiotics as pharmaceuticals is a growing trend that the recent development of microbiome-based therapeutics may have influenced. Significant progress is being made in the European Union (EU) to reclassify vaginal probiotics as pharmaceutical drugs.
Robust Investment in Research and Development
The potential of the human microbiome to transform the healthcare industry has led to a recent surge in investments in research and development. Trillions of bacteria, fungi, and viruses that live in and on the human body make up the human microbiome, which is essential to good health and the prevention and treatment of diseases. The development of therapies based on microbiomes is receiving significant funding from biotech startups and pharmaceutical companies. One of the first microbiome startups in India, Xome Life Sciences, for example, focuses on every facet of the microbiome. The company is developing prognostic, diagnostic, and therapeutic tools based on microbiomes to help people live healthier lives and make better decisions about their health. A recent FDA-approved treatment developed by Seres Therapeutics for recurrent Clostridium difficile infection, a gastrointestinal diseases targeted by microbiome-based drugs. Vedanta Biosciences raised substantial money to build their pipeline of immunotherapies derived from microbiomes for autoimmune disorders and cancer. Notable investors such as Seventure Partners and Flagship Pioneering are actively funding companies that analyze microbiome data, reflecting a growing recognition of the microbiome's role in health. Thus, significant investment in research and development is expected to drive advancements in precision medicine and therapeutic interventions, thereby creating ample opportunities in the market.
Human Microbiome Market Report Segmentation Analysis
Key segments that contributed to the derivation of the human microbiome market analysis are type, application, disease type, and geography.
- The human microbiome market, by type, is divided into product and software and services. The product segment is further bifurcated into probiotics and prebiotics. The product segment held a larger share of the human microbiome market in 2023, and it is expected to register a higher CAGR during 2023–2031.
- Based on application, the human microbiome market is categorized into therapeutics, diagnostics, and research. The therapeutics segment accounted for the largest share of the human microbiome market in 2023.
- Based on disease type, the human microbiome market is segmented into obesity, diabetes, autoimmune disorders, cancer, GIT Disorders, and others. The GIT Disorders segment held the largest share of the human microbiome market in 2023.
Human Microbiome Market Share Analysis by Geography
The geographic scope of the human microbiome market report is mainly divided into 5 major regions: North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America dominated the market in 2023. The market growth in North America is characterized by robust research activities on the human microbiome, increased funding for biotechnology, a rise in health consciousness among the population, and an increase in the demand for probiotics and prebiotics to treat chronic diseases. The applications of the human microbiome are rapidly growing in the field of biotechnology; it is emerging as a significant therapy to treat various chronic diseases. Research and development on human microbiome-based therapeutics has grown significantly in the US, leading to increased private investment and advances in environmental microbiome engineering. According to an article published in Nature in 2019, over the past decade, the US has made the largest investment of ~US$ 1 billion toward human microbiome research. Approximately 20% of this funding has been utilized for two phases of the Human Microbiome Project (HMP), which aims to create the necessary research resources for studying the human microbiome. HMP was launched in 2007 to establish a comprehensive toolbox consisting of reference data sets, computational techniques, analytical methods, and clinical protocols. This endeavor has proven to be successful, as roughly 75% of the NIH grant recipients for microbiome research from 2012 to 2016, working across more than 100 diseases, relied on HMP data and tools in their funding applications. Financed by the US National Institutes of Health (NIH), the HMP has significantly accelerated human microbiome research both within the US and on a global scale. The rise in research activities is likely to offer opportunities for the development of innovative therapies in the market.
Human Microbiome Market Report Scope
Human Microbiome Market News and Recent Developments
The human microbiome market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:
- MaaT Pharma announced the launch of a retrospective multicenter trial called CHRONOS in Europe. Its objective is to provide the Company efficacy data for 3rd-line therapies for patients not receiving MaaT013 or any microbiome intervention. This study was not requested by regulatory authorities and does not impact cash projections, as funding has already been secured. (Source: MaaT Pharma, Company Website, March 2024).
- Seres Therapeutics, Inc. has received U.S. Food and Drug Administration (FDA) clearance for SER-155 under an Investigational New Drug (IND) application. SER-155 is an investigational oral, rationally-designed, cultivated microbiome therapeutic designed to reduce the incidence of gastrointestinal antibiotic-resistant bacterial infections, bacteremia, and graft-versus-host disease (GvHD) in immunocompromised patients. (Source: Seres Therapeutics, Inc, Company Website, June 2021)
Human Microbiome Market Report Coverage and Deliverables
The "Human Microbiome Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Human microbiome market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Human microbiome market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Human microbiome market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the human microbiome market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product , Disease and Application and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
North America dominated the market in 2023.
Significant investments by key market players and government initiatives are among the most significant factors fueling the market growth.
The emergence of precision medicine is expected to emerge as a prime trend in the market in the coming years.
MaaT Pharma; Ferring Holdings SA; Finch Therapeutics Group Inc; AOBiome Therapeutics Inc.; Seres Therapeutics Inc; Merck & Co Inc; Yakult Honsha Co., Ltd; Rebiotix; Inc; IFF Nutrition & Biosciences; and Synthetic Biologics, Inc are among the key players in the market.
The human microbiome market value is expected to reach US$ 4.84 billion by 2031.
The market is expected to register a CAGR of 20.8% during 2023–2031.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Human Microbiome Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Human Microbiome Market – Key Market Dynamics
5.1 Human Microbiome Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Significant Investments by Key Market Players
5.2.2 Government Initiatives
5.3 Market Restraints
5.3.1 Challenges During Commercialization
5.4 Market Opportunities
5.4.1 Robust Investment in Research and Development
5.5 Future Trends
5.5.1 Emergence of Precision Medicine
5.6 Impact of Drivers and Restraints:
6. Human Microbiome Market – Global Market Analysis
6.1 Human Microbiome Market Revenue (US$ Million), 2021–2031
6.2 Human Microbiome Market Forecast Analysis
7. Human Microbiome Market Analysis – by Type
7.1 Product
7.1.1 Overview
7.1.2 Product: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Software and Services
7.2.1 Overview
7.2.2 Software and Services: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
8. Human Microbiome Market Analysis – by Application
8.1 Therapeutics
8.1.1 Overview
8.1.2 Therapeutics: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Diagnostics
8.2.1 Overview
8.2.2 Diagnostics: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Research
8.3.1 Overview
8.3.2 Research: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
9. Human Microbiome Market Analysis – by Disease Type
9.1 Obesity
9.1.1 Overview
9.1.2 Obesity: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Diabetes
9.2.1 Overview
9.2.2 Diabetes: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Autoimmune Disorder
9.3.1 Overview
9.3.2 Autoimmune Disorder: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Cancer
9.4.1 Overview
9.4.2 Cancer: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
9.5 GIT
9.5.1 Overview
9.5.2 GIT: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10. Human Microbiome Market – Geographical Analysis
10.1 Overview
10.2 North America
10.2.1 North America Human Microbiome Market Overview
10.2.2 North America: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3 North America: Human Microbiome Market Breakdown, by Type
10.2.3.1 North America: Human Microbiome Market – Revenue and Forecast Analysis – by Type
10.2.4 North America: Human Microbiome Market Breakdown, by Product
10.2.4.1 North America: Human Microbiome Market – Revenue and Forecast Analysis – by Product
10.2.5 North America: Human Microbiome Market Breakdown, by Application
10.2.5.1 North America: Human Microbiome Market – Revenue and Forecast Analysis – by Application
10.2.6 North America: Human Microbiome Market Breakdown, by Disease Type
10.2.6.1 North America: Human Microbiome Market – Revenue and Forecast Analysis – by Disease Type
10.2.7 North America: Human Microbiome Market – Revenue and Forecast Analysis – by Country
10.2.7.1 North America: Human Microbiome Market – Revenue and Forecast Analysis – by Country
10.2.7.2 United States: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.2.7.2.1 United States: Human Microbiome Market Breakdown, by Type
10.2.7.2.2 United States: Human Microbiome Market Breakdown, by Product
10.2.7.2.3 United States: Human Microbiome Market Breakdown, by Application
10.2.7.2.4 United States: Human Microbiome Market Breakdown, by Disease Type
10.2.7.3 Canada: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.2.7.3.1 Canada: Human Microbiome Market Breakdown, by Type
10.2.7.3.2 Canada: Human Microbiome Market Breakdown, by Product
10.2.7.3.3 Canada: Human Microbiome Market Breakdown, by Application
10.2.7.3.4 Canada: Human Microbiome Market Breakdown, by Disease Type
10.2.7.4 Mexico: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.2.7.4.1 Mexico: Human Microbiome Market Breakdown, by Type
10.2.7.4.2 Mexico: Human Microbiome Market Breakdown, by Product
10.2.7.4.3 Mexico: Human Microbiome Market Breakdown, by Application
10.2.7.4.4 Mexico: Human Microbiome Market Breakdown, by Disease Type
10.3 Europe
10.3.1 Europe Human Microbiome Market Overview
10.3.2 Europe: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3 Europe: Human Microbiome Market Breakdown, by Type
10.3.3.1 Europe: Human Microbiome Market – Revenue and Forecast Analysis – by Type
10.3.4 Europe: Human Microbiome Market Breakdown, by Product
10.3.4.1 Europe: Human Microbiome Market – Revenue and Forecast Analysis – by Product
10.3.5 Europe: Human Microbiome Market Breakdown, by Application
10.3.5.1 Europe: Human Microbiome Market – Revenue and Forecast Analysis – by Application
10.3.6 Europe: Human Microbiome Market Breakdown, by Disease Type
10.3.6.1 Europe: Human Microbiome Market – Revenue and Forecast Analysis – by Disease Type
10.3.7 Europe: Human Microbiome Market – Revenue and Forecast Analysis – by Country
10.3.7.1 Europe: Human Microbiome Market – Revenue and Forecast Analysis – by Country
10.3.7.2 United Kingdom: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.3.7.2.1 United Kingdom: Human Microbiome Market Breakdown, by Type
10.3.7.2.2 United Kingdom: Human Microbiome Market Breakdown, by Product
10.3.7.2.3 United Kingdom: Human Microbiome Market Breakdown, by Application
10.3.7.2.4 United Kingdom: Human Microbiome Market Breakdown, by Disease Type
10.3.7.3 Germany: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.3.7.3.1 Germany: Human Microbiome Market Breakdown, by Type
10.3.7.3.2 Germany: Human Microbiome Market Breakdown, by Product
10.3.7.3.3 Germany: Human Microbiome Market Breakdown, by Application
10.3.7.3.4 Germany: Human Microbiome Market Breakdown, by Disease Type
10.3.7.4 France: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.3.7.4.1 France: Human Microbiome Market Breakdown, by Type
10.3.7.4.2 France: Human Microbiome Market Breakdown, by Product
10.3.7.4.3 France: Human Microbiome Market Breakdown, by Application
10.3.7.4.4 France: Human Microbiome Market Breakdown, by Disease Type
10.3.7.5 Italy: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.3.7.5.1 Italy: Human Microbiome Market Breakdown, by Type
10.3.7.5.2 Italy: Human Microbiome Market Breakdown, by Product
10.3.7.5.3 Italy: Human Microbiome Market Breakdown, by Application
10.3.7.5.4 Italy: Human Microbiome Market Breakdown, by Disease Type
10.3.7.6 Spain: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.3.7.6.1 Spain: Human Microbiome Market Breakdown, by Type
10.3.7.6.2 Spain: Human Microbiome Market Breakdown, by Product
10.3.7.6.3 Spain: Human Microbiome Market Breakdown, by Application
10.3.7.6.4 Spain: Human Microbiome Market Breakdown, by Disease Type
10.3.7.7 Rest of Europe: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.3.7.7.1 Rest of Europe: Human Microbiome Market Breakdown, by Type
10.3.7.7.2 Rest of Europe: Human Microbiome Market Breakdown, by Product
10.3.7.7.3 Rest of Europe: Human Microbiome Market Breakdown, by Application
10.3.7.7.4 Rest of Europe: Human Microbiome Market Breakdown, by Disease Type
10.4 Asia Pacific
10.4.1 Asia Pacific Human Microbiome Market Overview
10.4.2 Asia Pacific: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3 Asia Pacific: Human Microbiome Market Breakdown, by Type
10.4.3.1 Asia Pacific: Human Microbiome Market – Revenue and Forecast Analysis – by Type
10.4.4 Asia Pacific: Human Microbiome Market Breakdown, by Product
10.4.4.1 Asia Pacific: Human Microbiome Market – Revenue and Forecast Analysis – by Product
10.4.5 Asia Pacific: Human Microbiome Market Breakdown, by Application
10.4.5.1 Asia Pacific: Human Microbiome Market – Revenue and Forecast Analysis – by Application
10.4.6 Asia Pacific: Human Microbiome Market Breakdown, by Disease Type
10.4.6.1 Asia Pacific: Human Microbiome Market – Revenue and Forecast Analysis – by Disease Type
10.4.7 Asia Pacific: Human Microbiome Market – Revenue and Forecast Analysis – by Country
10.4.7.1 Asia Pacific: Human Microbiome Market – Revenue and Forecast Analysis – by Country
10.4.7.2 China: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.4.7.2.1 China: Human Microbiome Market Breakdown, by Type
10.4.7.2.2 China: Human Microbiome Market Breakdown, by Product
10.4.7.2.3 China: Human Microbiome Market Breakdown, by Application
10.4.7.2.4 China: Human Microbiome Market Breakdown, by Disease Type
10.4.7.3 Japan: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.4.7.3.1 Japan: Human Microbiome Market Breakdown, by Type
10.4.7.3.2 Japan: Human Microbiome Market Breakdown, by Product
10.4.7.3.3 Japan: Human Microbiome Market Breakdown, by Application
10.4.7.3.4 Japan: Human Microbiome Market Breakdown, by Disease Type
10.4.7.4 India: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.4.7.4.1 India: Human Microbiome Market Breakdown, by Type
10.4.7.4.2 India: Human Microbiome Market Breakdown, by Product
10.4.7.4.3 India: Human Microbiome Market Breakdown, by Application
10.4.7.4.4 India: Human Microbiome Market Breakdown, by Disease Type
10.4.7.5 Australia: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.4.7.5.1 Australia: Human Microbiome Market Breakdown, by Type
10.4.7.5.2 Australia: Human Microbiome Market Breakdown, by Product
10.4.7.5.3 Australia: Human Microbiome Market Breakdown, by Application
10.4.7.5.4 Australia: Human Microbiome Market Breakdown, by Disease Type
10.4.7.6 South Korea: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.4.7.6.1 South Korea: Human Microbiome Market Breakdown, by Type
10.4.7.6.2 South Korea: Human Microbiome Market Breakdown, by Product
10.4.7.6.3 South Korea: Human Microbiome Market Breakdown, by Application
10.4.7.6.4 South Korea: Human Microbiome Market Breakdown, by Disease Type
10.4.7.7 Rest of APAC: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.4.7.7.1 Rest of APAC: Human Microbiome Market Breakdown, by Type
10.4.7.7.2 Rest of APAC: Human Microbiome Market Breakdown, by Product
10.4.7.7.3 Rest of APAC: Human Microbiome Market Breakdown, by Application
10.4.7.7.4 Rest of APAC: Human Microbiome Market Breakdown, by Disease Type
10.5 Middle East and Africa
10.5.1 Middle East and Africa Human Microbiome Market Overview
10.5.2 Middle East and Africa: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3 Middle East and Africa: Human Microbiome Market Breakdown, by Type
10.5.3.1 Middle East and Africa: Human Microbiome Market – Revenue and Forecast Analysis – by Type
10.5.4 Middle East and Africa: Human Microbiome Market Breakdown, by Product
10.5.4.1 Middle East and Africa: Human Microbiome Market – Revenue and Forecast Analysis – by Product
10.5.5 Middle East and Africa: Human Microbiome Market Breakdown, by Application
10.5.5.1 Middle East and Africa: Human Microbiome Market – Revenue and Forecast Analysis – by Application
10.5.6 Middle East and Africa: Human Microbiome Market Breakdown, by Disease Type
10.5.6.1 Middle East and Africa: Human Microbiome Market – Revenue and Forecast Analysis – by Disease Type
10.5.7 Middle East and Africa: Human Microbiome Market – Revenue and Forecast Analysis – by Country
10.5.7.1 Middle East and Africa: Human Microbiome Market – Revenue and Forecast Analysis – by Country
10.5.7.2 South Africa: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.5.7.2.1 South Africa: Human Microbiome Market Breakdown, by Type
10.5.7.2.2 South Africa: Human Microbiome Market Breakdown, by Product
10.5.7.2.3 South Africa: Human Microbiome Market Breakdown, by Application
10.5.7.2.4 South Africa: Human Microbiome Market Breakdown, by Disease Type
10.5.7.3 Saudi Arabia: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.5.7.3.1 Saudi Arabia: Human Microbiome Market Breakdown, by Type
10.5.7.3.2 Saudi Arabia: Human Microbiome Market Breakdown, by Product
10.5.7.3.3 Saudi Arabia: Human Microbiome Market Breakdown, by Application
10.5.7.3.4 Saudi Arabia: Human Microbiome Market Breakdown, by Disease Type
10.5.7.4 United Arab Emirates: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.5.7.4.1 United Arab Emirates: Human Microbiome Market Breakdown, by Type
10.5.7.4.2 United Arab Emirates: Human Microbiome Market Breakdown, by Product
10.5.7.4.3 United Arab Emirates: Human Microbiome Market Breakdown, by Application
10.5.7.4.4 United Arab Emirates: Human Microbiome Market Breakdown, by Disease Type
10.5.7.5 Rest of Middle East and Africa: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.5.7.5.1 Rest of Middle East and Africa: Human Microbiome Market Breakdown, by Type
10.5.7.5.2 Rest of Middle East and Africa: Human Microbiome Market Breakdown, by Product
10.5.7.5.3 Rest of Middle East and Africa: Human Microbiome Market Breakdown, by Application
10.5.7.5.4 Rest of Middle East and Africa: Human Microbiome Market Breakdown, by Disease Type
10.6 South and Central America
10.6.1 South and Central America Human Microbiome Market Overview
10.6.2 South and Central America: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3 South and Central America: Human Microbiome Market Breakdown, by Type
10.6.3.1 South and Central America: Human Microbiome Market – Revenue and Forecast Analysis – by Type
10.6.4 South and Central America: Human Microbiome Market Breakdown, by Product
10.6.4.1 South and Central America: Human Microbiome Market – Revenue and Forecast Analysis – by Product
10.6.5 South and Central America: Human Microbiome Market Breakdown, by Application
10.6.5.1 South and Central America: Human Microbiome Market – Revenue and Forecast Analysis – by Application
10.6.6 South and Central America: Human Microbiome Market Breakdown, by Disease Type
10.6.6.1 South and Central America: Human Microbiome Market – Revenue and Forecast Analysis – by Disease Type
10.6.7 South and Central America: Human Microbiome Market – Revenue and Forecast Analysis – by Country
10.6.7.1 South and Central America: Human Microbiome Market – Revenue and Forecast Analysis – by Country
10.6.7.2 Brazil: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.6.7.2.1 Brazil: Human Microbiome Market Breakdown, by Type
10.6.7.2.2 Brazil: Human Microbiome Market Breakdown, by Product
10.6.7.2.3 Brazil: Human Microbiome Market Breakdown, by Application
10.6.7.2.4 Brazil: Human Microbiome Market Breakdown, by Disease Type
10.6.7.3 Argentina: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.6.7.3.1 Argentina: Human Microbiome Market Breakdown, by Type
10.6.7.3.2 Argentina: Human Microbiome Market Breakdown, by Product
10.6.7.3.3 Argentina: Human Microbiome Market Breakdown, by Application
10.6.7.3.4 Argentina: Human Microbiome Market Breakdown, by Disease Type
10.6.7.4 Rest of South and Central America: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
10.6.7.4.1 Rest of South and Central America: Human Microbiome Market Breakdown, by Type
10.6.7.4.2 Rest of South and Central America: Human Microbiome Market Breakdown, by Product
10.6.7.4.3 Rest of South and Central America: Human Microbiome Market Breakdown, by Application
10.6.7.4.4 Rest of South and Central America: Human Microbiome Market Breakdown, by Disease Type
11. Competitive Landscape
11.1 Overview
11.2 Growth Strategies in the Human Microbiome Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 MaaT Pharma
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Ferring Holdings SA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 AOBiome Therapeutics Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Finch Therapeutics Group Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 SWOT Analysis
12.4.5 Key Developments
12.5 Seres Therapeutics Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Merck & Co Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Yakult Honsha Co., Ltd.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Rebiotix, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 IFF Nutrition & Biosciences
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Synthetic Biologics, Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 Glossary of Terms
13.2 About The Insight Partners
List of Tables
Table 1. Human Microbiome Market Segmentation
Table 2. Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 4. Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 5. Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 6. Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million) – by Disease Type
Table 7. North America: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 8. North America: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 9. North America: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 10. North America: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 11. North America: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 12. United States: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 13. United States: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 14. United States: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 15. United States: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 16. Canada: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 17. Canada: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 18. Canada: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 19. Canada: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 20. Mexico: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 21. Mexico: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 22. Mexico: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 23. Mexico: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 24. Europe: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 25. Europe: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 26. Europe: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 27. Europe: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 28. Europe: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 29. United Kingdom: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 30. United Kingdom: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 31. United Kingdom: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 32. United Kingdom: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 33. Germany: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 34. Germany: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 35. Germany: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 36. Germany: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 37. France: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 38. France: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 39. France: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 40. France: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 41. Italy: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 42. Italy: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 43. Italy: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 44. Italy: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 45. ADULT OBESITY, 2030
Table 46. CHILD OBESITY, 2030
Table 47. Spain: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 48. Spain: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 49. Spain: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 50. Spain: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 51. Rest of Europe: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 52. Rest of Europe: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 53. Rest of Europe: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 54. Rest of Europe: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 55. Asia Pacific: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 56. Asia Pacific: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 57. Asia Pacific: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 58. Asia Pacific: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 59. Asia Pacific: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 60. China: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 61. China: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 62. China: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 63. China: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 64. Japan: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 65. Japan: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 66. Japan: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 67. Japan: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 68. India: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 69. India: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 70. India: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 71. India: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 72. Australia: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 73. Australia: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 74. Australia: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 75. Australia: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 76. South Korea: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 77. South Korea: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 78. South Korea: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 79. South Korea: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 80. Rest of APAC: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 81. Rest of APAC: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 82. Rest of APAC: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 83. Rest of APAC: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 84. Middle East and Africa: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 85. Middle East and Africa: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 86. Middle East and Africa: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 87. Middle East and Africa: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 88. Middle East and Africa: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 89. South Africa: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 90. South Africa: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 91. South Africa: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 92. South Africa: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 93. Saudi Arabia: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 94. Saudi Arabia: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 95. Saudi Arabia: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 96. Saudi Arabia: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 97. United Arab Emirates: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 98. United Arab Emirates: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 99. United Arab Emirates: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 100. United Arab Emirates: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 101. Rest of Middle East and Africa: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 102. Rest of Middle East and Africa: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 103. Rest of Middle East and Africa: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 104. Rest of Middle East and Africa: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 105. South and Central America: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 106. South and Central America: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 107. South and Central America: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 108. South and Central America: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 109. South and Central America: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 110. Brazil: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 111. Brazil: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 112. Brazil: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 113. Brazil: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 114. Argentina: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 115. Argentina: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 116. Argentina: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 117. Argentina: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 118. Rest of South and Central America: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 119. Rest of South and Central America: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 120. Rest of South and Central America: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 121. Rest of South and Central America: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million) – by Disease Type
Table 122. Recent Organic Growth Strategies in the Human Microbiome Market
Table 123. Recent Inorganic Growth Strategies in the Human Microbiome Market
Table 124. Glossary of Terms, Microelectrode Array in Vitro Market
List of Figures
Figure 1. Human Microbiome Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Human Microbiome Market Revenue (US$ Million), 2021–2031
Figure 5. Human Microbiome Market Share (%) – by Type (2023 and 2031)
Figure 6. Product: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Software and Services: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Human Microbiome Market Share (%) – by Application (2023 and 2031)
Figure 9. Therapeutics: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Diagnostics: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Research: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Human Microbiome Market Share (%) – by Disease Type (2023 and 2031)
Figure 13. Obesity: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Diabetes: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Autoimmune Disorder: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Cancer: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. GIT: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Others: Human Microbiome Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Human Microbiome Market Breakdown by Region, 2023 and 2031 (%)
Figure 20. North America: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 21. North America: Human Microbiome Market Breakdown, by Type (2023 and 2031)
Figure 22. North America: Human Microbiome Market Breakdown, by Product (2023 and 2031)
Figure 23. North America: Human Microbiome Market Breakdown, by Application (2023 and 2031)
Figure 24. North America: Human Microbiome Market Breakdown, by Disease Type (2023 and 2031)
Figure 25. North America: Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. United States: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 27. Canada: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 28. Mexico: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 29. Europe: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 30. Europe: Human Microbiome Market Breakdown, by Type (2023 and 2031)
Figure 31. Europe: Human Microbiome Market Breakdown, by Product (2023 and 2031)
Figure 32. Europe: Human Microbiome Market Breakdown, by Application (2023 and 2031)
Figure 33. Europe: Human Microbiome Market Breakdown, by Disease Type (2023 and 2031)
Figure 34. Europe: Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 35. United Kingdom: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 36. Germany: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 37. France: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 38. Italy: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 39. Spain: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 40. Rest of Europe: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 41. Asia Pacific: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 42. Asia Pacific: Human Microbiome Market Breakdown, by Type (2023 and 2031)
Figure 43. Asia Pacific: Human Microbiome Market Breakdown, by Product (2023 and 2031)
Figure 44. Asia Pacific: Human Microbiome Market Breakdown, by Application (2023 and 2031)
Figure 45. Asia Pacific: Human Microbiome Market Breakdown, by Disease Type (2023 and 2031)
Figure 46. Asia Pacific: Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 47. China: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 48. Japan: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 49. India: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 50. Australia: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 51. South Korea: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 52. Rest of APAC: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 53. Middle East and Africa: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 54. Middle East and Africa: Human Microbiome Market Breakdown, by Type (2023 and 2031)
Figure 55. Middle East and Africa: Human Microbiome Market Breakdown, by Product (2023 and 2031)
Figure 56. Middle East and Africa: Human Microbiome Market Breakdown, by Application (2023 and 2031)
Figure 57. Middle East and Africa: Human Microbiome Market Breakdown, by Disease Type (2023 and 2031)
Figure 58. Middle East and Africa: Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 59. South Africa: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 60. Saudi Arabia: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 61. United Arab Emirates: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 62. Rest of Middle East and Africa: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 63. South and Central America: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 64. South and Central America: Human Microbiome Market Breakdown, by Type (2023 and 2031)
Figure 65. South and Central America: Human Microbiome Market Breakdown, by Product (2023 and 2031)
Figure 66. South and Central America: Human Microbiome Market Breakdown, by Application (2023 and 2031)
Figure 67. South and Central America: Human Microbiome Market Breakdown, by Disease Type (2023 and 2031)
Figure 68. South and Central America: Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 69. Brazil: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 70. Argentina: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 71. Rest of South and Central America: Human Microbiome Market – Revenue and Forecast to 2031(US$ Million)
Figure 72. Growth Strategies in the Human Microbiome Market
The List of Companies - Human Microbiome Market
- MaaT Pharma
- Ferring Holdings SA
- AOBiome Therapeutics Inc.
- Seres Therapeutics Inc
- Merck & Co Inc
- Yakult Honsha Co., Ltd
- Rebiotix, Inc
- IFF Nutrition & Biosciences,
- Synthetic Biologics, Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For